First proof-of-concept in vivo data for RNA editing using endogenous ADAR enzymes in alpha-1 antitrypsin deficiency ADAR editing resulted in therapeutically meaningful restoration of circulating ...
Quantum computing project aims to enhance the speed and quality of drug development processes to create first-in-class small molecule pharmaceuticals PALO ALTO, Calif.--(BUSINESS WIRE)-- D-Wave ...
Wave Life Sciences researchers have published positive preclinical proof-of-concept data showing the company’s adenosine deaminase acting on RNA (ADAR)-mediated RNA base editing technology to deliver ...
D-Wave’s hybrid-quantum application achieved a reduction in projected scheduling time from 10 hours using an industrial-grade classical solver to five seconds PALO ALTO, Calif.--(BUSINESS WIRE)-- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results